tradingkey.logo
tradingkey.logo
Search

China's Concord Medical Services H1 net loss narrows

ReutersSep 26, 2025 11:42 AM
facebooktwitterlinkedin
View all comments0


Overview

  • Concord Medical's H1 2025 revenue falls 8.3% yr/yr to RMB200.6 mln (US$28.0 million)

  • Net loss narrows to RMB27.1 mln (US$3.8 million) from RMB172.3 mln last year

  • Hospital business revenue up 11.1% due to proton therapy operations at Guangzhou Concord Cancer Hospital


Outlook

  • Company to advance proton therapy and enhance precision radiotherapy understanding

  • Concord Medical aims to expand access to advanced diagnostic technologies

  • Company plans to strengthen patient confidence in precision radiotherapy

  • Concord Medical committed to improving patient access to innovative medications


Result Drivers

  • PROTON THERAPY - Hospital business revenue increased by 11.1% due to the commencement of proton therapy operations at Guangzhou Concord Cancer Hospital

  • NETWORK BUSINESS DECLINE - Network business revenue fell 41.3% due to decreased demand for medical equipment and software and non-renewal of expired contracts

  • COST EFFICIENCY - Gross loss margin improved due to adjustments in revenue structure and strategic focus on enhancing operational efficiency and reducing costs


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

H1 Revenue

RMB 200.60 mln

H1 EPS

RMB 0.21

H1 Net Income

-RMB 27.10 mln

H1 Adjusted EBITDA

-RMB 62.20 mln

Press Release: ID:nPnbGX85Ba

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI